Acquiring Company
DataMeds AI
Acquired Company
Helomics Corporation
TampaPittsburghInformation TechnologyHealth CareArtificial IntelligenceMachine LearningBiotechnologyHealth CareArtificial IntelligenceDescription
DataMeds AI, Inc. has successfully completed the acquisition of Helomics Corporation. This strategic move aims to enhance Corexa Pharmacy's offerings in oncology and nutritional support products. DataMeds AI expects this acquisition to drive substantial growth and better meet the needs of patients managing Long COVID and other health conditions.
Fundz sees it the moment DataMeds AI makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Helomics Corporation?
Helomics Corporation was acquired by DataMeds AI, based in Tampa. The deal was reported on October 1, 2026. DataMeds AI, Inc. is a Health IT company focusing on integrating technology, pharmacy, and telemedicine services to improve healthcare experiences. DataMeds AI is publicly traded (MEDS) and operates in Information Technology.
When did DataMeds AI acquire Helomics Corporation?
DataMeds AI's acquisition of Helomics Corporation was reported on October 1, 2026. DataMeds AI, Inc. has successfully completed the acquisition of Helomics Corporation. This strategic move aims to enhance Corexa Pharmacy's offerings in oncology and nutritional support products. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Helomics Corporation do?
Helomics is a functional precision medicine oncology platform that utilizes artificial intelligence to analyze tumor data for drug discovery and treatment decisions. It is known for its innovative approaches in cancer diagnostics. It is privately held, operating in Biotechnology, and is based in Pittsburgh.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.